0.25
-0.0044(-1.73%)
Currency In USD
| Previous Close | 0.26 |
| Open | 0.25 |
| Day High | 0.26 |
| Day Low | 0.25 |
| 52-Week High | 1.78 |
| 52-Week Low | 0.24 |
| Volume | 418,881 |
| Average Volume | 1.63M |
| Market Cap | 22.12M |
| PE | -0.25 |
| EPS | -1 |
| Moving Average 50 Days | 0.35 |
| Moving Average 200 Days | 0.52 |
| Change | -0 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $84.95 as of March 14, 2025 at a share price of $0.251. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $48.57 as of March 14, 2025 at a share price of $0.251.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH
GlobeNewswire Inc.
Mar 11, 2025 11:30 AM GMT
Distribution agreements recently signed for France, Turkey, Romania and Morocco LungFit PH international distribution network now includes 18 countries Initial international orders for LungFit PH systems have been received for four countries GARDEN C
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences
GlobeNewswire Inc.
Mar 06, 2025 9:05 PM GMT
GARDEN CITY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve t
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
GlobeNewswire Inc.
Feb 05, 2025 2:29 PM GMT
GARDEN CITY, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th